Management of haematologic malignancies in pregnancy

Annals of the Academy of Medicine Singapore

Volumn 31, Issue 3, 2002, Pages 303-310

  Wong, Gee Chuan ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Chemotherapy; Fetus; Leukaemia; Lymphoma; Radiation

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT;

ABORTION; ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER PATIENT; CARCINOGENESIS; CONGENITAL MALFORMATION; DRUG METABOLISM; FEMALE; FETUS DEVELOPMENT; HEMATOLOGIC DISEASE; HUMAN; INDIVIDUALIZATION; IONIZING RADIATION; LEUKEMIA; LOW BIRTH WEIGHT; LYMPHOMA; PANCYTOPENIA; PREGNANCY; PREMATURITY; REVIEW; BLOOD DISEASE; CANCER STAGING; CAUSE OF DEATH; ECHOGRAPHY; MATERNAL MORTALITY; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PROGNOSIS; RADIOTHERAPY; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CAUSE OF DEATH; COMBINED MODALITY THERAPY; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MATERNAL MORTALITY; NEOPLASM STAGING; PATIENT CARE TEAM; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; PROGNOSIS; RADIOTHERAPY; TREATMENT OUTCOME; ULTRASONOGRAPHY, PRENATAL;

EID: 0036019096     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Cancer statistics, 1999
2. Hematologic malignancies during pregnancy
3. Radiation exposure in pregnancy
4. Obstetric MR imaging
5. Policies, guidelines and recommendations for MR imaging safety and patient management: SMRI safety committee
6. Plasma volume in normal first pregnancy
7. Physiologic changes during pregnancy and their implications for pharmacologic treatment
8. Anticancer drug pharmacodynamics
9. The fate of drugs in pregnancy
10. Evaluating the alleged teratogenicity of environmental agents
11. Aminopterin and methotrexate: Folic acid deficiency
12. Management of leukemia in pregnancy
13. Cytotoxic drugs in pregnancy
14. Fetal group C trisomy after cytosine arabinoside and thioguanine
15. Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy - A case report
16. Reproductive toxicity of alkylating agents
17. Anthracyclines in the treatment of malignancy in pregnancy
18. The effects of cancer chemotherapeutic agents on the developing fetus
19. Therapeutic abortion by means of X-rays
20. Therapeutic abortion produced by the roentgen ray
21. Fetal dose from radiotherapy with photon beams: Report of AAPM Radiation Therapy Committee Task Group No 36
22. Lymphoma and leukemia complicating pregnancy
23. Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin's disease
24. Acute leukemia and pregnancy
25. Congenital abnormalities in baby born to cytarabine treated mother
26. Pregnancy and leukemia
27. Acute leukemia and pregnancy. A review of management and outcome, 1972-1982
28. Acute promyelocytic leukemia during pregnancy. A case report
29. Interferon-alpha therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia
30. Two cases of CML treated with alpha-interferon during second and third trimester of pregnancy with analysis of the drug in the newborn immediately postpartum
31. Chronic lymphocytic leukemia in pregnancy
32. Pregnancy in association with a newly diagnosed cancer. A population-based epidemiologic assessment
33. Influence of pregnancy on the course of Hodgkin's disease
34. Cytotoxic therapy and pregnancy
35. Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early stage Hodgkin's disease: A meta-analysis of 23 randomised trials involving 3,888 patients
36. Treatment of early stage Hodgkin's disease: Lessons from recent studies. PPO Updates
37. Problems in Hodgkin's disease management
38. NCCN practice guidelines for Hodgkin's disease
39. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD or MOPP alternating with ABVD
40. Lymphoma and pregnancy
41. Lymphoma and pregnancy
42. Burkitt's lymphoma: Obstetric and gynaecologic aspects
43. Burkitt's lymphoma during pregnancy with bilateral breast involvement
44. Lymphoma in the elderly and in pregnancy
45. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma
46. Chemotherapy alone compared with chemotherapy plus radiotherapy for localised intermediate and high grade non-Hodgkin's lymphoma